Nalaganje...
Surfactin-based nanoparticles loaded with doxorubicin to overcome multidrug resistance in cancers
BACKGROUND: Multidrug resistance (MDR) is one of the major obstacles to successful cancer chemotherapy. Developing efficient strategies to reverse MDR remains a major challenge. Surfactin (SUR), a cyclic lipopeptide biosurfactant, has been found to display anticancer activity. METHODS: In this paper...
Shranjeno v:
| izdano v: | Int J Nanomedicine |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5868599/ https://ncbi.nlm.nih.gov/pubmed/29606866 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S157368 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|